Global Blood Therapeutics Inc. (GBT)

55.28
3.40 6.50
NASDAQ : Health Technology
Prev Close 51.90
Open 51.90
Day Low/High 51.77 / 55.45
52 Wk Low/High 30.15 / 64.94
Volume 1.16M
Avg Volume 777.30K
Exchange NASDAQ
Shares Outstanding 60.23M
Market Cap 3.08B
EPS -3.40
P/E Ratio N/A
Div & Yield N.A. (N.A)
There's No Rush for the Exits So Far

There's No Rush for the Exits So Far

There's lots of negativity, but dip buyers are showing up.

Market Is Home on the Range Again

Market Is Home on the Range Again

Emotion of yesterday's collapse is pretty much gone.

Regenxbio Leads Biotech Movers Ahead of Market's Open

Regenxbio Leads Biotech Movers Ahead of Market's Open

Also on the move were Global Blood Therapeutics, Valeant and Kite Pharma, among others.

Interesting GBT Put And Call Options For May 19th

Investors in Global Blood Therapeutics Inc saw new options begin trading this week, for the May 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GBT options chain for the new May 19th contracts and identified one put and one call contract of particular interest.

Traders Are Aggressively Fading the Open

Traders Are Aggressively Fading the Open

But what will be most important is whether support stays strong and the buyers show interest in the afternoon.

My Screen Looks Quite Bloody

My Screen Looks Quite Bloody

Not making any new buys, but I haven't rushed to make sales either.

Market Takes 'National Napping Day' Seriously

Market Takes 'National Napping Day' Seriously

U.S. stocks saw slow action ahead of the start of a Fed meeting and a big East Coast snow storm Tuesday.

Biotech Leads the Way Again Today

Biotech Leads the Way Again Today

This group has had some excellent speculative action lately while not much else has been working.

Rev's Forum: Bulls Still Believe, but Negative Catalysts are Building

Rev's Forum: Bulls Still Believe, but Negative Catalysts are Building

The markets' focus will be on the pace of future interest rate hikes.

Late Market Rally but No Bounce for Bulls

Late Market Rally but No Bounce for Bulls

We end the week with the same question we had at the start.

Egalet Makes Friday's Biotech Mailbag

Egalet Makes Friday's Biotech Mailbag

Why the name is sagging, and what it will take to spur the sector higher.

Shark Bites: Market Needs a Bounce in Its Step

Shark Bites: Market Needs a Bounce in Its Step

Biotechnology continues to be a bright spot.

Market Set Up for Oversold Bounce

Market Set Up for Oversold Bounce

We'll learn a lot from the market's action today

These Stocks Are Trending Up With Monster Volume

These Stocks Are Trending Up With Monster Volume

Let's take a look at several stocks that are experiencing unusual volume activity.

7 Stocks Trending Up With Monster Volume

7 Stocks Trending Up With Monster Volume

Here's a technical look at how to play a number of stocks trending higher with strong volume.

Global Blood Therapeutics Shares Jump on Report It Was Approached by Novo Nordisk

Global Blood Therapeutics Shares Jump on Report It Was Approached by Novo Nordisk

While it's not a surprise that Global Blood is a takeout target, the timing of Novo Nordisk's interest in the company comes as a surprise, according to a stock analyst.

Is This a Market Top or Just Consolidation?

Is This a Market Top or Just Consolidation?

Afternoon surge is surfacing again.

Global Blood Therapeutics Stock Surging on Nordisk Bid Speculation

Global Blood Therapeutics Stock Surging on Nordisk Bid Speculation

Global Blood Therapeutics is said to have been approached about a merger by Novo Nordisk.

Market Taking a Break, but Probably Not for Long

Market Taking a Break, but Probably Not for Long

Today is more about stock picking.

Markets Are Selling the Mnuchin News

Markets Are Selling the Mnuchin News

It is clear that tax policy isn't going to be solidified in a couple of weeks.

The Contrary Indicators Are Piling Up

The Contrary Indicators Are Piling Up

But it is all about timing, and so far there is no indication that this extended market is about to turn.

Interesting GBT Put And Call Options For April 21st

Investors in Global Blood Therapeutics Inc saw new options begin trading this week, for the April 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GBT options chain for the new April 21st contracts and identified one put and one call contract of particular interest.

Some Stock Picks on This Morning's Dip

Some Stock Picks on This Morning's Dip

It will be interesting to see today if afternoon strength occurs once again.

Argos Plummets 72%, Leads Biotech Movers

Argos Plummets 72%, Leads Biotech Movers

Also falling was Global Blood Therapeutics.

Trading in a Rising Market Simply Isn't as Simple as It May Seem

Trading in a Rising Market Simply Isn't as Simple as It May Seem

Finding new buys becomes more difficult, and knowing when to lock in gains isn't easy, either.